Showing results (481-490 of 1,919) with videos related to
Sort By:
Pageof 192
Cancer Biomarkers : Section a of Disease Markers|November 25, 2011
Bioinformatics: biomarkers of early detectionDaniel J Crichton, Chris A Mattmann, Mark Thornquist, et al.Cancer Biomarkers : Section a of Disease Markers|February 27, 2009
Frequent amplifications and deletions of G1/S-phase transition genes, CCND1 and MYC in early breast cancers: a potential role in G1/S escapeL B Jensen, J M S Bartlett, C J Witton, et al.Cancer Biomarkers : Section a of Disease Markers|October 10, 2019
Prognostic value of the combined expression of tumor-associated trypsin inhibitor (TATI) and p53 in patients with bladder cancer undergoing radical cystectomyAnwei Liu, Yongping Xue, Fei Liu, et al.Cancer Biomarkers : Section a of Disease Markers|October 10, 2019
Long non-coding RNA GAS5 regulates human B lymphocytic leukaemia tumourigenesis and metastasis by sponging miR-222Zhenhai Jing, Lei Gao, Hongzhou Wang, et al.Cancer Biomarkers : Section a of Disease Markers|January 31, 2022
Diagnosis and staging of HCV associated fibrosis, cirrhosis and hepatocellular carcinoma with target identification for miR-650, 552-3p, 676-3p, 512-5p and 147bAbdullah Ahmed Gibriel, Manal Fouad Ismail, Hameis Sleem, et al.Cancer Biomarkers : Section a of Disease Markers|October 18, 2021
Aberrant STAT1 methylation as a non-invasive biomarker in blood of HCV induced hepatocellular carcinomaUmaira Zakir, Nadir Naveed Siddiqui, Faizan-Ul-Hassan Naqvi, et al.Cancer Biomarkers : Section a of Disease Markers|October 18, 2021
Toll-like receptor 3 is a potential prognosis marker and associated with immune infiltration in stomach adenocarcinomaZhihao Huang, Aoxiao He, Jiakun Wang, et al.Cancer Biomarkers : Section a of Disease Markers|March 7, 2022
CDT1 facilitates metastasis in prostate cancer and correlates with cell cycle regulationChunhui Wang, Jizhong Che, Ying Jiang, et al.Cancer Biomarkers : Section a of Disease Markers|March 11, 2022
Mass spectrometry, data re-analysis, and homology modelling predict posttranslational modifications of leucine-rich alpha-2-glycoprotein as a marker of myelodysplastic syndromePavel Majek, Zofie Sovova, Klara Pecankova, et al.Cancer Biomarkers : Section a of Disease Markers|January 24, 2022
Identifying glycolysis-related LncRNAs for predicting prognosis in breast cancer patientsJiayue Zou, Yanlin Gu, Qi Zhu, et al.Pageof 192